|Bid||245.62 x 800|
|Ask||245.79 x 800|
|Day's range||244.32 - 247.79|
|52-week range||216.47 - 260.26|
|PE ratio (TTM)||92.91|
|Earnings date||29 Aug 2018 - 4 Sep 2018|
|Forward dividend & yield||0.06 (0.02%)|
|1y target est||271.46|
PLEASANTON, Calif., July 12, 2018-- The Cooper Companies, Inc. today announced that, consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual ...
This article is intended for those of you who are at the beginning of your investing journey and want to better understand how you can grow your money by investingRead More...
PLEASANTON, Calif., June 07, 2018-- The Cooper Companies, Inc. today announced financial results for the fiscal second quarter ended April 30, 2018.. Revenue increased 21% year-over-year to $631.3 million. ...
Holly Sheffield has been appointed Executive Vice President and Chief Strategy Officer of The Cooper Companies, effective June 4, 2018. In this position, Holly will be responsible for corporate strategy, business development and global human resources with a strong focus on driving long-term shareholder value. Holly will report directly to Albert White, President and CEO.
PLEASANTON, Calif., May 21, 2018-- The Cooper Companies, Inc. will present at the Goldman Sachs Healthcare Conference in Rancho Palos Verdes, CA, on June 14, 2018. Daniel G. McBride, Esq, Executive Vice ...
ResMed (RMD) presents the company-sponsored health economic studies, Home Oxygen Therapy-Home Mechanical Ventilation (HOT-HMV), at the ATS 2018 International Conference.
PLEASANTON, Calif., May 17, 2018-- The Cooper Companies, Inc. will present at the William Blair Growth Stock Conference in Chicago, Illinois, on June 13, 2018. Albert G. White III, President and Chief ...
Medtronic (MDT) focuses on boosting CSH segment. Notably, successful results from The Bifurcation Cohort study will help the company to achieve expanded FDA approval for the Resolute Onyx DES.
Cardinal Health (CAH) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions as well.
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support.
PLEASANTON, Calif., April 23, 2018-- The Cooper Companies, Inc. today announced that Brian Andrews has been promoted to Senior Vice President, Chief Financial Officer and Treasurer of The Cooper Companies ...
Cooper Companies (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.